Article info
Basic and translational research
Extended report
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
- Correspondence to Dr Michal Tomcik, First Faculty of Medicine, Department of Rheumatology, Institute of Rheumatology, Charles University, Na Slupi 4, 128 50 Prague 2, Czech Republic; michaltomcik{at}yahoo.com
Citation
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Publication history
- Accepted April 14, 2013
- First published May 9, 2013.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions